person · Reporting owner
Kurzius Lawrence Erik
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | September 16, 2026 | September 17, 2026 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | August 20, 2026 | August 21, 2026 |
| Lamb Weston Holdings, Inc.LW · Entity 3684 | Director | October 08, 2026 | October 09, 2026 |
| MCCORMICK & CO INCMKC · Entity 1416 | 10% owner | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date September 16, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,099 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Purchase · Acquired 10,000 · Balance 31,099 |
Elanco Animal Health Inc
Report date August 20, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 188,647 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Purchase · Acquired 40,000 · Balance 188,647 F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Lamb Weston Holdings, Inc.
Report date October 08, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,054 |
Reported balance
After 2026-10-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-08 · Grant · Acquired 5,458 · Balance 11,054 F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement. F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.
F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.
MCCORMICK & CO INC
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - VotingSEC Table I · non-derivative | Direct | 296,992 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Exercise / conversion · Acquired 205,538 · Balance 502,530 Row 2 · 2026-08-10 · Sale · Disposed 205,538 · Balance 296,992 |
| Options - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2027-03-29 | Direct | 0 |
Reported balance
After 2026-08-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-10 · Exercise / conversion · Disposed 205,538 · Balance 0 F1: Option exercised; no purchase price required. |
Filing footnotes · ownership attribution and instrument terms
F1: Option exercised; no purchase price required.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2022 Filed Jan 3, 2023 22:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 750.1367 | $12.22 | $9,166.67 |
DisclosureSEC source: 0001415889-23-000091 · form4-01032023_100126.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,214.568 Underlying: Common Stock · 750.1367 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 712.251 | $12.87 | $9,166.67 |
DisclosureSEC source: 0001415889-22-011972 · form4-12022022_101203.xml · derivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,464.4313 Underlying: Common Stock · 712.251 shares Expires not disclosed F2 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022. F3 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022. F2 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-011972 · form4-12022022_101203.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,916 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:27 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 694.9712 | $13.19 | $9,166.67 |
DisclosureSEC source: 0001415889-22-010995 · form4-11022022_011133.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,752.1803 Underlying: Common Stock · 694.9712 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| October 25, 2022 Filed Jan 25, 2023 18:19 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 145.65 | $76.13 | $11,088.33 |
DisclosureSEC source: 0001062993-23-001361 · form4.xml · derivative · entry 9 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non Qualified Retirement Savings Plan Disclosed balance after: 30,113.934 Underlying: Common Stock - Voting · 145.65 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment. F1 · derivative.exercise_date: Dividend Reinvestment. F1 · derivative.expiration_date: Dividend Reinvestment. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 21:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Non Voting | 2,500 | $74.53 | $186,324.25 |
DisclosureSEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 21:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Non Voting | 2,500 | $74.30 | $185,750.00 |
DisclosureSEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 9 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherCommon Stock - Non Voting | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: Exchange of shares of Common Stock - Voting for shares of Common Stock - Non-Voting on a one for one basis. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherCommon Stock - Voting | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,898 F1 · price: Exchange of shares of Common Stock - Voting for shares of Common Stock - Non-Voting on a one for one basis. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 738.6519 | $12.41 | $9,166.67 |
DisclosureSEC source: 0001415889-22-010280 · form4-10042022_021057.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,057.2091 Underlying: Common Stock · 738.6519 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 605.8605 | $15.13 | $9,166.67 |
DisclosureSEC source: 0001415889-22-009257 · form4-09022022_010919.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,318.5572 Underlying: Common Stock · 605.8605 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 452.4516 | $20.26 | $9,166.67 |
DisclosureSEC source: 0001415889-22-008117 · form4-08022022_010838.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,712.6967 Underlying: Common Stock · 452.4516 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| July 25, 2022 Filed Jan 25, 2023 18:19 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 130.545 | $84.57 | $11,040.19 |
DisclosureSEC source: 0001062993-23-001361 · form4.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Plan Disclosed balance after: 29,968.284 Underlying: Common Stock - Voting · 130.545 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment. F1 · derivative.exercise_date: Dividend Reinvestment. F1 · derivative.expiration_date: Dividend Reinvestment. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:33 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions- Right to Buy · Derivative | 17,806 | $0.00 Strike: $83.25 | $0.00 |
DisclosureSEC source: 0001062993-22-015972 · form4.xml · derivative · entry 11 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,806 Underlying: Common Stock - Voting · 17,806 shares Expires not disclosed F6 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. F6 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:32 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 466.9725 | $19.63 | $9,166.67 |
DisclosureSEC source: 0001415889-22-007334 · form4-07052022_010737.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,260.2451 Underlying: Common Stock · 466.9725 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:52 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 386.7793 | $23.70 | $9,166.67 |
DisclosureSEC source: 0001415889-22-006044 · form4-06022022_040621.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,793.2726 Underlying: Common Stock · 386.7793 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| April 29, 2022 Filed May 3, 2022 21:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 362.1758 | $25.31 | $9,166.67 |
DisclosureSEC source: 0001415889-22-004544 · form4-05032022_020537.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,406.4933 Underlying: Common Stock · 362.1758 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| April 27, 2022 Filed Jul 5, 2022 22:33 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 2,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-015972 · form4.xml · nonDerivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2020 GRAT B Disclosed balance after: 7,655 F2 · price: Shares gifted; No Purchase price required. F1 · balance_after: Upon termination of the Reporting Person's 2020 grantor retained annuity trusts, the Reporting Person gifted 4,418 shares of Common Stock - Voting and transferred 10,892 shares of Common Stock - Voting evenly into two new separate grantor retained annuity trusts created on June 30, 2022. Read SEC document |
| April 27, 2022 Filed Jul 5, 2022 22:33 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 2,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-015972 · form4.xml · nonDerivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2020 GRAT A Disclosed balance after: 7,655 F2 · price: Shares gifted; No Purchase price required. F1 · balance_after: Upon termination of the Reporting Person's 2020 grantor retained annuity trusts, the Reporting Person gifted 4,418 shares of Common Stock - Voting and transferred 10,892 shares of Common Stock - Voting evenly into two new separate grantor retained annuity trusts created on June 30, 2022. Read SEC document |
| April 27, 2022 Filed Jul 6, 2022 20:03 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 2,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-016060 · form4a.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2020 GRAT B Disclosed balance after: 0 F1 · price: Shares gifted; No Purchase price required. F2 · balance_after: The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned by the reporting person indirectly through the reporting person's 2020 GRATs following the reported transactions. Read SEC document |
| April 27, 2022 Filed Jul 6, 2022 20:03 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 2,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-016060 · form4a.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2020 GRAT A Disclosed balance after: 0 F1 · price: Shares gifted; No Purchase price required. F2 · balance_after: The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned by the reporting person indirectly through the reporting person's 2020 GRATs following the reported transactions. Read SEC document |
| April 25, 2022 Filed Jul 5, 2022 22:33 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 107.457 | $102.37 | $11,000.37 |
DisclosureSEC source: 0001062993-22-015972 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Plan Disclosed balance after: 29,837.739 Underlying: Common Stock - Voting · 107.457 shares Expires not disclosed F4 · derivative.exercise_price: Dividend Reinvestment. F4 · derivative.exercise_date: Dividend Reinvestment. F4 · derivative.expiration_date: Dividend Reinvestment. F5 · balance_after: This amount reflects 299.064 shares acquired through Dividend Reinvestment and not previously reported on the Reporting Person's previous Form 4. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:54 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 351.348 | $26.09 | $9,166.67 |
DisclosureSEC source: 0001415889-22-003755 · form4-04042022_020422.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,044.3175 Underlying: Common Stock · 351.348 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 30, 2022 Filed Apr 1, 2022 15:39 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions- Right to Buy · Derivative | 194,219 | $0.00 Strike: $97.26 | $0.00 |
DisclosureSEC source: 0001062993-22-009177 · form4.xml · derivative · entry 9 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,219 Underlying: Common Stock - Voting · 194,219 shares Expires not disclosed F2 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. F2 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. Read SEC document |
| March 30, 2022 Filed Jun 2, 2022 20:23 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions- Right to Buy · Derivative | 178,368 | $0.00 Strike: $97.26 | $0.00 |
DisclosureSEC source: 0001062993-22-014143 · form4a.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,368 Underlying: Common Stock - Voting · 178,368 shares Expires not disclosed F1 · derivative.exercise_date: The option grant becomes exercisable in thirds of the first three (3) grant anniversaries. F1 · derivative.expiration_date: The option grant becomes exercisable in thirds of the first three (3) grant anniversaries. F2 · balance_after: Due to an administrative error, the Reporting Person's previous Form 4 filed on April 1, 2022 incorrectly reported the Reporting Person receiving an option grant of 194,219 shares of Common Stock - Voting when it should have been reported as 178,368 shares of Common Stock - Voting. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 7,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-008017 · form4.xml · derivative · entry 13 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,970 Underlying: Common Stock - Voting · 7,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required. F6 · price: Restricted Stock Units granted on April 1, 2020. F5 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023. F5 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 6,994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-008017 · form4.xml · derivative · entry 12 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 6,994 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required. F4 · price: Restricted Stock Units granted on March 27, 2019 F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2020, March 15, 2021 and March 15, 2022 F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2020, March 15, 2021 and March 15, 2022 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 3,661 | $96.99 | $355,080.39 |
DisclosureSEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,898 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 7,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 3 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units; No purchase price required. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 3,214 | $96.99 | $311,725.86 |
DisclosureSEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,593 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 19:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 6,994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units; No purchase price required. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 322.6565 | $28.41 | $9,166.67 |
DisclosureSEC source: 0001179110-22-001941 · edgar.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,692.9695 Underlying: Common Stock · 322.6565 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| February 13, 2022 Filed Feb 15, 2022 19:18 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 39,224 | $101.02 | $3,962,212.36 |
DisclosureSEC source: 0001062993-22-004413 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,813 F1 · shares: Shares withheld for taxes on the shares previously reported on 1/26/2022 for McCormick's Long-Term Incentive Plan. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionOptions - Right to Buy · Derivative | 90,000 | $0.00 Strike: $35.55 | $0.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · derivative · entry 17 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 90,000 shares Expires 2024-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Options Exercised. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Voting | 90,000 | $100.09 | $9,007,659.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 6 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,037 Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 90,000 | $35.55 | $3,199,500.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 352.0226 | $26.04 | $9,166.67 |
DisclosureSEC source: 0001179110-22-000724 · edgar.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,370.313 Underlying: Common Stock · 352.0226 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionOptions- Right to Buuy · Derivative | 8,400 | $0.00 Strike: $35.55 | $0.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · derivative · entry 16 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 8,400 shares Expires 2024-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Options Exercised. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Voting | 8,400 | $98.00 | $823,200.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,037 Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 8,400 | $35.55 | $298,620.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 3 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 20:34 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 81,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-001605 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,037 F1 · shares: Shares awarded pursuant to McCormick's Long-Term Incentive Program (LTIP) for the three (3) year performance cycle beginning on December 1, 2018 and ending on November 30, 2021. Read SEC document |
| January 10, 2022 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 115.803 | $94.62 | $10,957.28 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · derivative · entry 15 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Plan Disclosed balance after: 29,431.22 Underlying: Common Stock - Voting · 115.803 shares Expires not disclosed F2 · derivative.exercise_price: Dividend Reinvestment. F2 · derivative.exercise_date: Dividend Reinvestment. F2 · derivative.expiration_date: Dividend Reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 22:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 322.9975 | $28.38 | $9,166.67 |
DisclosureSEC source: 0001179110-22-000132 · edgar.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,018.2904 Underlying: Common Stock · 322.9975 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 318.9516 | $28.74 | $9,166.67 |
DisclosureSEC source: 0001179110-21-010541 · edgar.xml · derivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,695.2929 Underlying: Common Stock · 318.9516 shares Expires not disclosed F2 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. F3 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. F2 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 7,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010541 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,267 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 27, 2021 Filed Dec 1, 2021 21:08 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 28,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-011888 · form4.xml · derivative · entry 10 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 28,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required. F4 · price: The Restricted Stock Units granted on November 27, 2018. F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning on November 27, 2019, November 27, 2020 and November 27, 2021. F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning on November 27, 2019, November 27, 2020 and November 27, 2021. Read SEC document |
| November 27, 2021 Filed Dec 1, 2021 21:08 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 13,545 | $86.24 | $1,168,120.80 |
DisclosureSEC source: 0001062993-21-011888 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,829 F2 · balance_after: Due to administrative error, the Reporting Person's previous Form 4 filed on March 15, 2021 incorrectly reported the Reporting Person's direct holdings of Common Stock - Voting as 177,849 when it should have been reported as 174,332. Read SEC document |
| November 27, 2021 Filed Dec 1, 2021 21:08 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 28,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-011888 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units; No purchase price required. Read SEC document |
| November 08, 2021 Filed Feb 1, 2022 19:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GiftCommon Stock - Voting | 12,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,037 F1 · price: Shares gifted; no purchase price required. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:29 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 217.9644 | $32.88 | $7,166.67 |
DisclosureSEC source: 0001179110-21-009768 · edgar.xml · derivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,376.3413 Underlying: Common Stock · 217.9644 shares Expires not disclosed F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021. F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.